How A Stock Moves Up From Pink Sheets To The Major Exchanges

Posted by: VIC  /  Category: Investor Education

Pink sheet stocks are considered by most to be extremely risky stocks. These are companies with very little public information and financial disclosure. Many times they are shell companies with paper stocks and without any product or service that has an acceptable market. Due to its lax nature of public disclosure, it is hard to attract new capital either from new shareholders or from bond issuers. However, a move from pink sheets to a listed security can do wonders in a company’s ability to raise capital in the market place.
* Please Login or Register to continue reading...

PGOG - 25% Pullback From Lows

Posted by: VIC  /  Category: 25% Pullback From Lows

Perf Go Green Holdings, Inc. operates as a biodegradable plastics company. The company intends to develop eco-friendly, non-toxic, food contact compliant, biodegradable plastic products as a practical and viable solution to eliminate plastic waste from the world environment. It focuses on marketing and distributing biodegradable plastic products that would include the 13 gallon kitchen trash bags and 30 gallon lawn and leaf bags. Perf Go Green Holdings principally targets mass retailers to market its products in the United States and Canada. The company is based in New York, New York.

PGOG  AT 9:55 AM 1/16/2009: 25% Pullback From Lows

OXBO - Running Up Briskly

Posted by: VIC  /  Category: Running Up Briskly

Oxygen Biotherapeutics, Inc. develops biotechnology products. It focuses on developing Oxycyte, a product alternative to transfused blood for use in surgical and similar medical situations. Oxycyte blood substitute product is a perfluorocarbon emulsified with water and a surfactant, which is provided to the patient intravenously. The properties of perfluorocarbon enable the product to gather oxygen from the lungs and transport the oxygen through the body releasing it along the way. Oxycyte is intended as a transfusion substitute for blood transfusion that ordinarily would be applied in cases of trauma, surgery (emergency and elective), unexpected blood loss, and other general medical applications. The company also develops Fluorovent, an oxygen exchange fluid for facilitating the treatment of lung conditions; and a biosensor implant product that uses an enzyme process for measuring the glucose level in subcutaneous fluid. In addition, it holds patents pertaining to the use and application of perfluorocarbons as gas transport agents in blood substitutes and liquid ventilation. The company, formerly known as Synthetic Blood International, Inc., was founded in 1967 and is based in Costa Mesa, California.

OXBO at 9:46 AM 1/16/2009: Running Up Briskly

LBAS - Trading 5% Above VWAP

Posted by: VIC  /  Category: Trading Above VWAP

Location Based Technologies, Inc., a development stage wireless technology company, focuses on the development, marketing, and sale of a personal location device system for retail distribution in the United States. It develops the PocketFinder Personal Locator or PocketFinder, a small personal location device designed to locate children, elderly or disabled persons, and pets, as well as to track valued personal property. The company was founded in 2005 and is headquartered in Anaheim, California.

LBAS at 9:40 AM 1/15/2009:  Trading 5% above VWAP

BSIC - Running up

Posted by: GCM  /  Category: Running Up Briskly

Basic Earth Science Systems, Inc. engages in the exploration, acquisition, development, operation, production, and sale of crude oil and natural gas in the United States. It focuses in the North Dakota and Montana portions of the Williston basin, the Denver-Julesburg basin of Colorado, the southern portions of Texas, and the onshore portions of the Gulf Coast. As of March 31, 2008, the company owned working interest in 90 producing oil wells and 14 producing gas wells in the states of North Dakota, Montana, Colorado, Texas, and Wyoming. Its estimated proved developed oil and gas reserves were 1,229,000 barrels of oil equivalent. The company was founded in 1969 and is based in Denver, Colorado.

BSIC at 9:32 AM 1/15/2009:  Running up

KITD - Price Crossed Above 50 Day SMA

Posted by: GCM  /  Category: 50 Day SMA Cross

KIT digital, Inc., through its subsidiaries, engages in providing Internet software products and solutions that enable customers to distribute video content through the Web sites and mobile devices. Its core activities include video player deployment, ingestion and transcoding, localization, content syndication, digital rights management, hosting, storage, and content delivery. The company, through its Internet protocol television (IPTV) enablement, provides integrated marketing solutions, including strategic planning, creative services, media planning and buying, design services, brand and retail advertising, and data management and analytics. KIT digital offers a customized online video platform that enables clients to publish, manage, and distribute content; build communities; and integrate advertising. It also provides a range of traditional advertising services, including media buying and planning, creative development, and packaging. The company, formerly known as ROO Group, Inc., was founded in 1998 and is headquartered in New York, New York with additional offices in Dubai, the United Arab Emirates; Melbourne, Australia; Bogota, Columbia; and London, the United Kingdom.

KITD at 10:05 AM 1/14/2009:  Price Crossed Above 50 Day SMA

OXBO - Running Up Briskly

Posted by: GCM  /  Category: Running Up Briskly

Oxygen Biotherapeutics, Inc. develops biotechnology products. It focuses on developing Oxycyte, a product alternative to transfused blood for use in surgical and similar medical situations. Oxycyte blood substitute product is a perfluorocarbon emulsified with water and a surfactant, which is provided to the patient intravenously. The properties of perfluorocarbon enable the product to gather oxygen from the lungs and transport the oxygen through the body releasing it along the way. Oxycyte is intended as a transfusion substitute for blood transfusion that ordinarily would be applied in cases of trauma, surgery (emergency and elective), unexpected blood loss, and other general medical applications. The company also develops Fluorovent, an oxygen exchange fluid for facilitating the treatment of lung conditions; and a biosensor implant product that uses an enzyme process for measuring the glucose level in subcutaneous fluid. In addition, it holds patents pertaining to the use and application of perfluorocarbons as gas transport agents in blood substitutes and liquid ventilation. The company, formerly known as Synthetic Blood International, Inc., was founded in 1967 and is based in Costa Mesa, California.

OXBO at 10:09 AM 1/14/2009:  Running Up Briskly

 1 2 3 4 5 6 7 8 ...21 22 23 Next